References
- Friedman E. L., Garnick M. B., Stomper P. C., Mauch P. M., Harrington O. P., Richie J. P. Therapeutic guidelines and results in advanced seminoma. J. Clin. Oncol. 1985; 3: 1325
- Jochelson M., Mauch P., Balikian J., Rosenthal D. The significance of the residual mediastinal mass in treated Hodgkin's disease. J. Clin. Oncol. 1985; 3: 637
- Jochelson M., Torbell N., Weinstein H. Unusual thoracic radiographic findings in children treated for Hodgkin's disease. J. Clin. Oncol. 1986; 4: 874
- Marc Stewart F., Brian R. W., Donald J. I., Charles E. H. Residual tumors disease following treatment for advanced histiocytic lymphoma. Cancer 1985; 55: 620
- Radford J. A., Cowan R. A., Flanagan M., Crowther D., Johnson R. J., Eddleston B. The significance of residual mediastinal widening following treatment for Hodgkin's disease. The Third International Conference on Malignant Lymphoma, Abstract 27, Lugano, June 10–13, 1987
- Rustad D., Stolar C, Amodio J. Residual or reccurent anterior chest mass (AMC) in Hodgkin's disease (HD). ASCO Proceedings, Abstract 1986; 754: 192
- Young R. C., Longo D. L., Glatstein E., Hubbard S., Duffey P., Devita V. T. Hodgkin's disease. NCI trials addressing the remaining challenges. The Third International Conference on Malignant Lymphoma, Abstract 17, Lugano, June 10–13, 1987